Welcome to the team Joe Davis! We are thrilled to announce that Dr. Joe Davis joins our team as Director of Data Science. Excited to see what you will accomplish!
Character Biosciences
生物技术
San Francisco，CA 4,730 位关注者
A patient-driven drug discovery platform for diseases of aging
关于我们
Character Biosciences (formerly Clover Therapeutics) is a precision medicine platform that is unlocking the patterns of age-related diseases in people of diverse backgrounds. Our mission is to use human genetics to understand what drives diseases so we can discover targeted therapies to more effectively treat patients - many of whom lack any treatment options today. Character partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts to enable clinical genomic research. Our approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines.
- 网站
-
https://www.characterbio.com
Character Biosciences的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- San Francisco，CA
- 类型
- 私人持股
- 创立
- 2019
地点
Character Biosciences员工
动态
-
We are thrilled to announce that Character Biosciences was selected to participate in Stanford University Graduate School of Business’s dy/dx program! Members of our management team have been in Palo Alto for the last three weeks learning from the incredible faculty and impressive cohort of founders and executives. Thank you to Stanford, Accel, Index Ventures, Lightspeed, Sequoia Capital, Innovation Endeavors for this transformative experience!
On Sunday we were overjoyed to welcome our third cohort of dy/dx at Stanford University Graduate School of Business with 53 leaders coming from 23 amazing startups! We have a diverse set of inspiring companies this year ranging from Seed to Series C and in various industries, from #gaming, to #robotics, to #petcare, and more, with of course a lot of #AI! A big thank you to our Venture Allies for continuing to support their founders through the dy/dx program! Accel, Index Ventures, Innovation Endeavors, Lightspeed, and Sequoia Capital #GSBExecEd #GSBdydx #startups
-
-
Happy Pride Month! At Character Biosciences, we recognize the invaluable contributions that LGBTQ+ scientists make in ophthalmology and all of STEM. To recognize LGBTQ+ scientists in STEM, Character Biosciences is giving back to Out in Science, Technology, Engineering & Mathematics (oSTEM), the largest chapter-based 501(c)(3) non-profit association dedicated to serving LGBTQ+ students and professionals around the world. ?We are proud to stand with the LGBTQ+ community and endeavor to build a vibrant and successful scientific community by embracing all individuals, regardless of sexual orientation or gender identity. Together we can create a society where everyone feels empowered to be their authentic selves, for Pride Month and beyond. Happy Pride Month from all of us at Character Bio!? #LGBTQinSTEM #PrideMonth “Science is a universal language that transcends borders, cultures, and identities. It thrives on diversity, inclusivity, and equality.” -Graduate Women in Science, LA chapter
-
Look forward to take part in ARVO next week, and proud to share some the exciting work from the Character Bio labs!
We're thrilled to announce that we'll be presenting at ARVO 2024! ?? We can't wait to connect with you and share our latest advancements. Catch us at the following presentations, and feel free to view their abstracts attached below: 1?? Poster B0216 - https://bit.ly/PosterB0216 2?? Poster B1009 - https://bit.ly/PosterB1009 3?? Presentation 6156 - https://lnkd.in/enhTMQKW #ARVO2024 #CharacterBio #AMD #VisionResearch #Ophthalmology
-
-
We're thrilled to announce that we'll be presenting at ARVO 2024! ?? We can't wait to connect with you and share our latest advancements. Catch us at the following presentations, and feel free to view their abstracts attached below: 1?? Poster B0216 - https://bit.ly/PosterB0216 2?? Poster B1009 - https://bit.ly/PosterB1009 3?? Presentation 6156 - https://lnkd.in/enhTMQKW #ARVO2024 #CharacterBio #AMD #VisionResearch #Ophthalmology
-
-
Did you know that February is Age-related Macular Degeneration (AMD) and Low Vision Awareness Month? At Character Biosciences, we conduct clinical genomic research into the causes of AMD onset and progression and develop precision therapies for this condition. You can explore more about our research efforts on our website: https://characterbio.com/? #AMD #VisionLoss #EyeHealthAwareness Prevent Blindness
-
We are excited to share the news that our partners at Innovation Endeavors just unveiled a new $630 million fund to invest in world-changing ideas. Character Biosciences stands with pride among other mission-driven visionaries in leveraging data, computation, and engineering to build toward a brighter and healthier future.
Today we announce Fund V — a $630 million fund we’re putting toward visionaries at the intersection of science and technology who are tackling audacious challenges to build a brighter future. ? This fund allows us to continue our core strategy and partner with founders from inception through growth to build generational companies solving our most pressing issues. And to all who are a part of our Innovation Endeavors community, thank you. Your commitment to shaping a better world is what drives us to do more. Together, let’s shape the future!
Announcing Fund V: $630 million to partner with visionaries in a world of rapid change
Dror Berman，发布于领英
-
Excited and honored that Character Bio has been selected to join NVIDIA Healthcare's Inception start-up accelerator program! Services like NVIDIA MONAI will help us scale our AI-enabled phenotyping of image biomarkers for #drugdiscovery in complex diseases like #AgeRelatedMacularDegeneration
NVIDIA #BioNeMo enables #GenerativeAI for #DrugDiscovery on @AWS. Researchers and developers can now easily deploy NVIDIA Clara? software and services through Amazon Web Services. https://nvda.ws/3R0ZWPU #AWSreInvent
-